Probiotics, Nuclear Receptor Signaling, and Anti-Inflammatory Pathways
2011

Probiotics and Their Role in Inflammatory Bowel Disease

publication Evidence: moderate

Author Information

Author(s): Sonia S. Yoon, Jun Sun

Primary Institution: University of Rochester Medical Center

Hypothesis

Probiotics may have beneficial effects on inflammatory bowel disease through various mechanisms, including nuclear receptor signaling.

Conclusion

Probiotics show promise in treating inflammatory bowel disease, but more well-designed studies are needed to confirm their efficacy.

Supporting Evidence

  • Probiotics have been shown to improve intestinal mucosal function.
  • Different strains of probiotics have varying effects on inflammatory bowel disease.
  • Probiotics can modulate immune responses and enhance barrier function in the gut.

Takeaway

Probiotics are good bacteria that can help your tummy feel better, especially if you have a sick gut.

Methodology

The paper reviews existing literature on probiotics and their mechanisms of action in relation to inflammatory bowel disease.

Potential Biases

Heterogeneity in study designs and probiotic strains may introduce bias in the results.

Limitations

There is a lack of large, well-designed randomized controlled trials to support the use of probiotics in clinical practice.

Digital Object Identifier (DOI)

10.1155/2011/971938

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication